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Abstract
Background and Purpose
In acute ischemic stroke (AIS) management, CT-based thrombus density has been associ-
ated with treatment success. However, currently used thrombus measurements are prone
to inter-observer variability and oversimplify the heterogeneous thrombus composition. Our
aim was first to introduce an automated method to assess the entire thrombus density and
then to compare the measured entire thrombus density with respect to current standard
manual measurements.
Materials and Method
In 135 AIS patients, the density distribution of the entire thrombus was determined. Density dis-
tributions were described using medians, interquartile ranges (IQR), kurtosis, and skewedness.
Differences between themedian of entire thrombusmeasurements and commonly applied
manual measurements using 3 regions of interest were determined using linear regression.
Results
Density distributions varied considerably with medians ranging from 20.0 to 62.8 HU and
IQRs ranging from 9.3 to 55.8 HU. The average median of the thrombus density distribu-
tions (43.5 ± 10.2 HU) was lower than the manual assessment (49.6 ± 8.0 HU) (p<0.05).
The difference between manual measurements and median density of entire thrombus
decreased with increasing density (r = 0.64; p<0.05), revealing relatively higher manual
measurements for low density thrombi such that manual density measurement tend overes-
timates the real thrombus density.
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Conclusions
Automatic measurements of the full thrombus expose a wide variety of thrombi density dis-
tribution, which is not grasped with currently used manual measurement. Furthermore, dis-
crimination of low and high density thrombi is improved with the automated method.
Introduction
Fast restoration of blood flow is key to successful acute ischemic stroke treatment. The Ameri-
can Heart/Stroke association recommends intra-venous thrombolysis with alteplase, as an
early treatment after the exclusion of intracranial hemorrhage on non-contrast CT (NCCT)
[1]. However some thrombi fail to dissolve and for these patients intra-arterial treatment
should be considered [2]. A main challenge in current ischemic stroke management is the
selection of patients in which either intra-arterial or intravenous treatment would be advanta-
geous. Recent research shows that thrombus length measured on NCCT (>8mm) is a potential
predictor of Intra-venous Thrombolysis (IVT) failure [3]. However, commonly smaller
thrombi do not dissolve after administration of IVT and therefore thrombus length has limited
value in predicting thrombolysis success. Understanding the composition of the thrombus may
provide additional information to support determination of the most promising treatment. For
this goal, thrombus composition has been studied by means of its density values on CT imag-
ing[4].
Studies have related the presence of an hyperdense artery sign—a visual mark of intralum-
inal thrombus on non-contrast CT- with success of restoring cerebral perfusion, stroke sever-
ity, and functional outcome [5–15]. Although the specificity of detecting hyperdense thrombi
is high, its sensitivity is rather low [16]. As an alternative to the qualitative classification of
hyperdense artery sign, it has been proposed to quantitatively measure thrombus density. This
measurement can be performed by placing one or multiple small regions of interest (ROIs) in
the thrombus on NCCT–for example using measuring tools available on diagnostic worksta-
tions [17–19]. Some studies have successfully related thrombus density with success of restor-
ing cerebral perfusion, stroke severity, and functional outcome. However, other studies did not
find such an association [20,21].
The drawback of the current manual thrombus density assessment using small ROIs is that
this procedure is prone to inter-observer variability and observer bias [22]. Furthermore, due
to the small size of the ROIs with respect to the thrombus volume, this measurement is sensi-
tive to partial volume effects, noise and may be highly variable due to the heterogeneous
thrombus composition [23]. To circumvent this, we developed an automated segmentation
method to segment the thrombus in CTA images [24]. The method performs automated den-
sity measurements of the entire thrombus rather than characterizing this thrombus with a sin-
gle value. In this study, we investigate the additional information provided by entire thrombus
density assessment and evaluate its agreement with current standard manual measurements.
Material and Methods
Patient Selection
Baseline NCCT and CT Angiography (CTA) image data sets of Three-hundred-eighty-eight
patients with a clinical diagnosis of acute ischemic stroke due to proximal intracranial arterial
occlusion were retrospectively collected in the multi-center image database of the MR CLEAN
clinical trial [2]. Following guidelines [25] indicating that for accurate thrombus representation
Automated Entire Thrombus Density Measurements for AIS Patients
PLOS ONE | DOI:10.1371/journal.pone.0145641 January 14, 2016 2 / 16
org/project/medusa.html). The MR CLEAN trial—from
which the study data were retrospectively collected—
was funded by the Dutch Heart Foundation (http://
www.carisma-airspace.nl), and through unrestricted
grants from AngioCare BV, Covidien/EV31, MEDAC
Gmbh/LAMEPRO and Penumbra Inc. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests:Wiro J. Niessen is co-founder
and shareholder of Quantib BV; Albert J. Yoo
received a research grant from Penumbra Inc. and a
research grant from Neuravi Inc.; Charles M. B.
Majoie received a research grant from Stryker Inc.
slice thickness smaller or equal to 2.5 mm are required, datasets with slice thickness larger than
2.5 mm (n = 199) were excluded. Further exclusion criteria were low image quality due to
movement artefacts (n = 39) or extensive noise on either NCCT or CTA (n = 3), poor contrast
(n = 3), a scan range not including the complete intracranial artery tree (n = 4), and scans with-
out visible contralateral vessel (n = 2) assessed by at least one expert observer. It is common
practice to initiate IV thrombolysis after completion of the NCCT, which may alter the throm-
bus [26]. To avoid bias due to thrombus change between NCCT and CTA, patients with a time
difference between CTA and NCCT imaging exceeding 30 minutes and patients that showed a
difference in the thrombus position or size on the two imaging modalities were also excluded
(n = 3). The remaining 135 patients were included in this study. Detailed information about
the scanners, scanning protocol, and reconstruction parameters can be found in Table 1.
Ethic statement
The MR CLEAN study protocol was approved by the Medical and Ethical Review Committee
(Medisch Ethische Toetsings Commissie of the Erasmus MC, Rotterdam, The Netherlands)
and the research board of each participating center (Academic Medical Center Amsterdam;
Maastricht University Medical Center, Maastricht; Sint Antonius Hospital, Nieuwegein; Leiden
University Medical Center, Leiden; Rijnstate Hospital, Arnhem; MC Haaglanden, the Hague;
HAGA Hospital, the Hague; University Medical Center Utrecht; Radboud University Medical
Center, Nijmegen; Sint Elisabeth Hospital, Tilburg; Isala Klinieken, Zwolle; Reinier de Graaf
Gasthuis, Delft; VU Medical Center, Amsterdam; University Medical Center Groningen;
AtriumMedical Center, Heerlen; Catharina Hospital, Eindhoven; Medical Spectrum Twente,
Enschede; Sint Lucas Andreas Hospital, Amsterdam; all in the Netherlands). All patient rec-
ords and images were anonymized prior to analysis. All patients or legal representatives signed
informed consent.
Automated Density Measurement of entire thrombi
For density measurement of the entire thrombus an automated thrombus segmentation
method as previously described [24] was used. This method segments the thrombus in CTA
images in three steps: (1) segmentation of the contralateral vasculature using 2 manually placed
seeds points by a trained observer (ES); (2) segmentation of the occluded artery by mapping
the contralateral segmentation to the occluded artery using mirror symmetry; (3) thrombus
segmentation using intensity based region growing. By performing a rigid registration of the
CTA and NCCT scans (Elastix1[27], University Medical Center Utrecht, The Netherlands),
the CTA-based thrombus segmentation was automatically projected on NCCT. If visual
inspection revealed that the thrombus segmentation was suboptimally registered, a correction
could be performed using manual rigid registration tools (developed in Mevislab1[28], MeVis
Medical Solutions AG, Fraunhofer MEVIS, Bremen, Germany). Finally, the density distribu-
tion of the entire thrombus was sampled in the entire thrombus on NCCT, and thrombus vol-
ume was measured in mm3.
Manual Thrombus Density Measurement
Manual thrombus density measurements were performed as previously described[22]. In
short, three standardized small spherical regions of interest were placed simultaneously within
the thrombus on the registered CTA and NCCT images using in-house developed annotation
software (Fig 1). Subsequently, absolute thrombus densities were determined. The previously
described annotations were performed by three neuroradiologists (AY, LB and CM), each with
more than 10 years of experience. Observer 1, as reference observer, measured all 135 patients,
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Observer 2 and 3 measured respectively 77 and 61 patients for interobserver agreement deter-
mination. They only had access to baseline NCCT and CTA images during thrombus assess-
ment and were blinded from measured density and all clinical information.
Table 1. Information about the scanners, scanning parameters, and reconstructions parameters of
the scanners used in this study.
n patients
Scanner manufacturer and model
GE MEDICAL SYSTEMS 13
LightSpeed VCT 13
PHILIPS 24
Brilliance 40 10
Brilliance 64 5
iCT 256 9
SIEMENS 52
Biograph 64 2
Sensation 64 22
SOMATOM Deﬁnition AS+ 3
SOMATOM Deﬁnition Flash 25
TOSHIBA 46
Aquilion ONE 46
Tube voltage (KVP)
100 2
120 133
Slice Thickness reconstruction (mm)
0.5 75
0.75< 24
1< 27
1.5< 6
2 3
Convolution kernel types
FCXX* 20
FLXX* 26
HXXx* 45
J45s\X* 7
SOFT 13
UA 2
UB 22
Filter types
none 29
FLAT 28
LARGE 26
MEDIUM 19
SMALL 9
UA 2
UB 22
*Kernel type details: FC22, FC25, FC26, FC27, FC28, FC29, FC30, FC31, FC32, FC33, FC34, FC35,
FC36, FC69, FC70, FC71, FC72, FL01, FL02, FL03, FL04, FL05, FL06, FL07, FL08, FL09, FL10, FL11,
FL12, FL13, FL14, FL15, FL16, FL17, FL18, FL19, FL20, FL21, FL22, FL23, H30f, H31s, H41s, H60s,
H70h, J45s\10, J45s\11, J45s\4, J45s\5, J45s\6, J45s\7, J45s\8, J45s\9.
doi:10.1371/journal.pone.0145641.t001
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Statistical Analysis
The density distribution of the entire thrombus was represented with median, interquartile
range (IQR), skewedness, and kurtosis. Normality of the distribution was assessed using the
Shapiro-Wilk test. The average density values, standard deviation (SD), and the range of the
medians of all the density distributions were determined. Associations between the median
density, volume, and IQR of the entire thrombus were determined by calculation of the Pear-
son’s correlation coefficient (PCC). The manual measurements resulted in one average density
value per thrombus per observer. Mean, SD, and range was used to describe all the variation of
these manual measurements. Interobserver agreement was assessed using Bland-Altman analy-
sis and the Intraclass correlation coefficient (ICC). To assess the agreement between manual
measurements and the density distribution of the entire thrombus, we compared the manual
measurements with the median and IQR of the measurement of the entire thrombus using the
same statistical analysis. Difference in mean and median intensities was investigated using a
paired t-test. Subsequently, the association of manual measurements with thrombus volume
Fig 1. Example of registered NCCT (left column) and CTA (right column) images of a patient suffering
from an M1 occlusion (white arrows). The green overlay (on the left) represents the manually measured
density using the three spherical ROI. On the right panel, the red overlay highlights the result of the
automated thrombus segmentation on CTA.
doi:10.1371/journal.pone.0145641.g001
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and density spread (IQR) was investigated using scatter plots and calculation of the PCC. To
assess potential bias due to variations in slice thickness and reconstruction convolution kernel
on measured density, (1) correlations between slice thickness and thrombus median density
was assessed by the calculation of the PCC and (2) differences between the average median
density per reconstruction kernel was evaluated using a non-parametric ANOVA. Significance
level was set to p-value 0.05. All analyses were performed using IBM SPSS Statistics software,
version 20.0 (IBM Corporation, Armonk, NY, USA).
Results
The average age was 65 (± 13) years and 63% (86) of the patients were male. The occlusion site
was in the Internal Carotid Artery (ICA) and ICA-Terminus in 24% of the cases (n = 32), in the
middle cerebral arteries segment M1 in 64% (n = 87) of the cases, and in the M2 in 12% (n = 16)
of the cases. Automated thrombus segmentation was successful for all patients. Twenty out of
135 (15%) patients required additional manual correction of the CTA to NCCT registration.
Examples of density distributions resulting from entire thrombus segmentations for six
patients are provided in Fig 2. All thrombus characteristics are presented in Table 2 and in the
supporting information dataset 1 (S1 Dataset). For the density distribution of the entire
thrombus, the average mean and median were 42.9 ± 9.0 HU and 43.4 ± 10.2 HU respectively.
The average thrombus volume was 52 ± 38 mm3, and the average IQR width was 20.3 ± 7.4
HU. In nineteen percent (n = 26) of the thrombi, the density was normally distributed.
No statistically significant association was found between the mean density values and the
thrombus volume and the spread (SD) of the density measures (Table 3). Manually assessed
thrombus density, with an average value of 49.6 ± 8.0 HU was significantly higher than the
median (Δ = 6.2 HU) and mean (Δ = 6.7 HU) value of the automatically derived density distri-
butions (p< 0.05). Fig 3 shows box-plots of 30 randomly selected patients with their
Fig 2. Histograms of density distribution of six automatically segmented entire thrombi. The colored vertical lines indicate the observer density
measurements (blue for observer 1, red for observer 2 and green for observer 3). The purple curve represents the fitted normal curve.
doi:10.1371/journal.pone.0145641.g002
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corresponding manual measurements. The original voxel density measures for this set are
available in the supporting information dataset 2 (S2 Dataset). Interobserver analysis (Fig 4)
revealed an ICC of 0.87 between observer 1 and 2, and an ICC of 0.72 for observer 1 and 3.
Regression analysis showed an agreement between the manual measurement of the reference
observer and the average density of the thrombus of a constant value of 11.7 (95%CI: 5.3–18.1)
HU and a slope of 0.64 (95%CI: 0.50–0.80), a PCC of 0.52, and a R2 of 0.29. Statistically signifi-
cant associations were found between the reference manual density measurements and the
thrombus IQR and thrombus volume; however the coefficient of determination were very
small with R2 of 0.03 and 0.04 respectively (Fig 5 and Table 3). There was no statistically signif-
icant correlation between slice thickness and measured median density of the thrombus
(PCC = 0.067, p = 0.44). The non-parametric ANOVA analysis showed no significant differ-
ences between the different convolution kernels (p = 0.35).
Table 3. Results of statistical analyses relatingmanual thrombus density measurements andmedian
value of the entire thrombusmeasurements with the heterogeneity of the thrombus, as expressed by
the inter-quartile range (IQR) of the entire thrombusmeasurement and with the thrombus volume in
mm3.
Statistical analysis Thrombus IQR (HU) Thrombus volume (mm3)
Manual thrombus measurement (Average)
Slope 0.14* 0.04*
Intercept 12.6 47.6
PCC 0.17 0.19
R2 0.03 0.04
Entire thrombus measurement (Median)
Slope -0.003 -0.002
Intercept 20.6 43.6
PCC 0.07 0.06
R2 0.05 0.001
* p  0.05
doi:10.1371/journal.pone.0145641.t003
Table 2. Descriptive statistics of the assessment of entire thrombus and the manual density
measurements.
Average SD Min Max
Density (in HU) and Volume (in mm3) of the entire thrombi (n = 135)
Mean 42.9 9.0 20.3 61.7
Median 43.4 9.9 20.0 64.0
SD 13.6 3.4 6.5 24.3
Minimum 9.3 9.9 0.0 37.0
Maximum 75.1 12.0 45.0 120.0
Interquartile Range 30.3 7.4 9.3 55.8
Skewedness -0.1 0.4 -1.3 2.1
Kurtosis -0.3 0.7 -1.4 4.6
Volume 52.2 38.1 5.0 189.6
Density (in HU) of the manual assessments
Observer 1 (n = 135) 51 7.5 26.5 71.8
Observer 2 (n = 77) 50.4 8.1 24.3 72.2
Observer 3 (n = 61) 45.5 7.6 28.0 61.5
All Observers (n = 273) 49.6 8.0 24.3 72.2
doi:10.1371/journal.pone.0145641.t002
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Discussion
We have introduced an automated method for entire thrombus density assessment on CT,
which provides information of the whole thrombus density distribution rather than represent-
ing the thrombus density with a single value, as obtained with the current manual measure-
ment. Our study showed large variation in the density histograms among thrombi, indicating
Fig 3. Density distributions of a randomly selected set of 30 patients and corresponding manual
measurements. The boxplots represent the first to third quartile the density distribution of the entire
thrombus segmentation. The vertical lines indicate the variability outside the Q1 and Q3. The colored circles
indicate the observer density measurements (blue for observer 1, red for observer 2 and green for observer
3).
doi:10.1371/journal.pone.0145641.g003
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that entire thrombus measurement provides more information than the conventional measure-
ments. Notably, the comparison of the entire thrombus density distributions with the manual
measurements has shown that manual measurements of low-density thrombi are overesti-
mated compared to high-density thrombi. This decreases differences in intensity measure-
ments between low and high dense thrombus, thereby reducing its discriminating power.
Consequently, the use of entire thrombus density measurements may improve the distinction
of low from high dense thrombi.
Usually, thrombus density is assessed by visual inspection (e.g., hyperdense artery sign)
[16]. Quantitative assessment of thrombus density was introduced as support to visual inspec-
tion [29]. These quantitative measurements established the relation between thrombus density
and thrombus composition derived from histology: platelet-rich thrombi were found to have
lower densities on NCCT than red blood cell-rich thrombi [4,30]. The entire thrombus density
distribution assessment as presented in this study, determines the range of densities within a
single thrombus and could conceivably be used to measure the heterogeneity of the thrombus
composition. Because the ratio of thrombus components (e.g. red and white blood cells, fibrin,
debris) influences the thrombus response to fibrinolysis [31], retrieving information on the
composition from baseline imaging could allow a better identification of patients who are likely
to benefit from IVT.
We found that manual thrombus density assessments were significantly higher than the
median density measured of the whole thrombus. This bias was negatively correlated with
median thrombus density. This implies that for a thrombus with a low density, the manually
measured density is overestimated. This overestimation of low dense thrombi reduces the den-
sity difference between low- and high-density thrombi. As a consequence, this reduced
Fig 4. Bland-Altman graph assessing the Interobserver agreements of Observer 2 and Observer 3
with the reference Observer 1. The colors indicate pairs of observers (blue for observer 1 and observer 2,
and green for observer 1 and observer 3). The color dotted lines represent the limits of agreements; the solid
line represents the mean paired difference.
doi:10.1371/journal.pone.0145641.g004
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difference in measured density may explain why strong association of thrombus density with
treatment success that was found some studies [19] could not be confirmed in other studies
[20,21].
Our study has some limitations. First, there is a lack of a gold standard for evaluation of the
accuracy of the thrombus density measurements. As such, the accuracy of the automated
method could not be determined. Instead, we compared the difference between the median of
the density distribution measured by the automated method with manual measurements.
However, this measurement is prone to interobserver variation most likely due to variation in
composition within the thrombus [23]. On the other hand, a more extensive manual measure-
ment of the thrombus could be performed; for example, perform a complete manual segmenta-
tion of the thrombus (e.g. using a combinations of the segmentation of the thrombus in every
slices [19] or using a multiple step manual delineation method[24]) such that measurement
bias due to the thrombus heterogeneity would be reduced. However, to our knowledge, these
more extensive methods are hardly applicable to low–dense thrombi. Alternatively, validation
of the density measures could be performed by comparison with histological analysis of
retrieved thrombus[4,18]. However, these histological analyses of retrieved thrombus were not
available and therefore such a comparison could not be performed. Interobserver agreement
was good. Due to the indistinct borders of some thrombi, it is possible that a part of stagnant
blood was included in the segmentation and consequently in the thrombus density measure-
ments, leading to a biased estimation of the thrombus density. The automated segmentation
method used in our study was design to avoid inclusions of stagnant blood with the use of a
finely tuned intensity based region growing segmentation [24], which was validated using man-
ually segmented thrombi on NCCT. The validation suggested that, at most, only a minimal
amount of unclotted blood was included into the thrombus segmentation by the automated
method.
Forty-one out of 197 scans had movement artefacts on CTA or NCCT, preventing accurate
registration, which is a prerequisite for the automated method. This limits the applicability of
the automated approach in clinical practice. Two patients had multiple contralateral occlu-
sions, hampering the automated segmentation. As a consequence, in our population of patients
with proximal large vessel occlusions of the anterior circulation, the automatic density mea-
surement could not be used for seventeen percent (17%) of the patients. Due to the imbalanced
availability of our expert observers (Observer 2 and 3) during the assessment of the thrombus
density, the measurements were unequally divided amongst the observers. However, we do not
expect that this has influenced interobserver analysis and comparison with the full thrombus
measurements[32]. It is expected that an entire thrombus measurement is more sensitive to
partial volume effects since the edges of the thrombus are also included in the measurements.
Partial volume effects result in an underestimation of high density signal, particularly for small
thrombi. However we could not find a significant association between measured median den-
sity and thrombus volume. Moreover, no significant correlation between measured median
and slice thickness was found, suggesting that partial volume effect due to slice thickness recon-
struction was not very severe in our analysis. The applied reconstruction kernels may influence
measured thrombus densities; however, in this study no significant differences were found,
implying that no correction was necessary. As this study is a retrospective analysis of a
Fig 5. Scatter plot of the manual thrombus density measurement compared to the thrombus
measured of the entire thrombus (A), Scatter plot of the manual thrombus density measurement
compared to the thrombus volume(B). Scatter plot of the manual thrombus density measurement
compared to the thrombus density IQR (C). The colors indicate the different observers (blue for observer
1, red for observer 2, and green for observer 3).
doi:10.1371/journal.pone.0145641.g005
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prospective trial[2], further studies should be performed to demonstrate the feasibility of this
method in acute clinical setting. Finally, although entire thrombus density measurement gives
a much more extensive estimation of thrombus density information, the therapeutic implica-
tions was beyond the scope of this study. Further analysis will be performed to evaluate entire
thrombus density associations with treatment efficiency. Accurate information on thrombus
density is important for assessing its association with outcome or treatment success [31]. With
an increasing number of available treatment options, precise characterization of the target is
required to enable optimal treatment selection for a given type and size of thrombus[33].
Although density measurement of entire thrombus requires supplementary resources (software
and/or processing time), we believe that the resulting thrombus characterization would support
better AIS management.
Conclusion
Our study exposed large variations in shapes of density histograms in thrombi, indicating that
currently used manual measurement result in oversimplification of thrombus characteristics.
Automated density measurements of entire thrombi have the potential to enhance the discrim-
ination between low and high dense thrombi and consequently may guide treatment decision
and predict responsiveness. Further multicentre studies on larger cohorts are necessary to con-
firm our results in other populations.
Supporting Information
S1 Dataset. Dataset containing all measured thrombi characteristics and corresponding
manual density measures. The contained characteristics are volume, mean, median, standard
deviation, skew, kurtosis and interquartile range.
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S2 Dataset. Dataset containing the all the densities in HU of each voxel constituting the
thrombi of the example set of 30 patients.
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